Cannabis consumer packaged goods company Green Thumb Industries Inc. GTII GTBIF reported second-quarter revenue of $44.7 million, up 228% year-over-year, and a record quarter-over-quarter growth of 60%.
EBITDA was a loss of $9.4 million, while adjusted operating EBTIDA was positive and marked a gain of $5.0 million. The company disclosed net loss for the quarter of $22.2 million, versus a net loss of $9.7 million in the previous quarter.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
GTI’s brand portfolio sales in the quarter were higher 276% year-over-year, and 70% quarter-over-quarter.
In May, Green Thumb Industries closed $105.5 million senior secured non-brokered private placement of notes, which shall be used for usual working capital purposes, the company said.
See Also: Green Thumb Industries Enters New York With Fiorello Acquisition
During the second quarter, the company launched Beboe Therapies, a CBD-infused skin-care line, completed the acquisition of Integral Associates LLC, which broadened its distribution in Nevada. The company also acquired MC Brands LLC and expanded its retail footprint in California with three license wins.
“We are pleased to report another solid quarter of positive yet disciplined momentum with record revenue and positive adjusted operating EBITDA as our strategic plan delivers on operating efficiencies from scale. Continued execution of key priorities such as the closing of Integral Associates, accelerated store openings, and expanded distribution of our brand portfolio sets us up well for the future,” Ben Kovler, Green Thumb’s Founder and CEO said in a statement.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.